FundedIQ
Biotechnology

Clarapath: Funding, Investors & Team (Oct 2026)

Clarapath is a medical robotics company that aims to automate laboratory processes. Their initial product focuses on automating the microtomy station in pathology. The company's goal is to revolutionize the field of anatomic pathology by improving lab medicine, enhancing safety standards, increasing lab efficiency, and reducing costs and delays. Their advanced laboratory at the NY Genome Center, along with their image repository and analysis platform, can handle all steps in the tissue processing pipeline for research and clinical purposes. Clarapath collaborates with both research and clinical partners to deliver quicker and more precise outcomes.

www.clarapath.com LinkedIn New York, United States 11-50 employees
Total raised
$36.0M
Rounds
1
Latest
Series B
Jul 2024

Clarapath has raised $36.0M across 1 funding round on record, the most recent a Series B of $36.0M announced in Jul 2024.

That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Clarapath Company Profile and Key Stats

Total funding raised
$36.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series B
$36.0M in Jul 2024
Employees
11-50
reported band
Headquarters
New York, United States

Latest funding round on record: Jul 2024.

Clarapath Funding Rounds

Date
Round
Amount
Series B
$36.0M

Clarapath Founders and Leadership Team

Name
Role
Contact
Partha Mitra
Founder
Locked

Contact details for the Clarapath team: 1 of 1 has an email address on file.

Start 14-day free trial →

Clarapath Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.4M
30,319
$7.7M
4,422
$32M

Clarapath's latest round of $36.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Clarapath in Biotechnology and New York

Companies Similar to Clarapath

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…

Series A $37.0M
Series B $150M

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Clarapath Funding FAQs

What does Clarapath do?

Clarapath is a medical robotics company that aims to automate laboratory processes. Their initial product focuses on automating the microtomy station in pathology. The company's goal is to revolutionize the field of anatomic pathology by improving lab medicine, enhancing safety standards, increasing lab efficiency, and reducing costs and delays. Their advanced laboratory at the NY Genome Center, along with their image repository and analysis platform, can handle all steps in the tissue processing pipeline for research and clinical purposes. Clarapath collaborates with both research and clinical partners to deliver quicker and more precise outcomes.

How much funding has Clarapath raised?

Clarapath has raised $36.0M across 1 round on record. The most recent is a Series B of $36.0M announced in Jul 2024.

When did Clarapath last raise funding?

Clarapath's most recent funding round on record is a Series B of $36.0M, announced in Jul 2024.

Who founded Clarapath?

FundedIQ lists Partha Mitra (Founder) at Clarapath.

Where is Clarapath headquartered?

Clarapath is based in New York, United States.

How many employees does Clarapath have?

Clarapath is in the 11-50 employee band.

How does Clarapath's funding compare to other Biotechnology startups?

Clarapath's latest round of $36.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Clarapath Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Clarapath is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.